Alnylam Pharmaceuticals (A1LN34.SA) Q2 2015 Earnings

7MayConfirmed
Q3 2014
Q4 2014
Q1 2015
Q2 2015
-1.96
-1.57
-1.18
-0.79

Details

Expected EPS
-1.963845
Actual EPS
-1.8732060000000001
Surprise EPS
0.09
Surprise Percent
+4.62%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.8732060000000001 per share for Q2 2015.

0 Comments

Share your thoughts